Stock-Based Compensation (Tables)

12 Months Ended

Jan. 28, 2024

Share-Based Payment Arrangement [Abstract]

Schedule of Stock-Based Compensation Expense, Net of Amounts Capitalized as Inventory

Our Consolidated Statements of Income include stock-based compensation expense, net of amounts allocated to inventory, as follows:

	Year Ended
	Jan 28, 2024		Jan 29, 2023		Jan 30, 2022
	(In millions)
Cost of revenue	$	141	$	138	$	141
Research and development	2,532		1,892		1,298
Sales, general and administrative	876		680		565
Total	$	3,549	$	2,710	$	2,004

Schedule of Equity Awards

The following is a summary of equity awards granted under our equity incentive plans:

	Year Ended
	Jan 28, 2024		Jan 29, 2023		Jan 30, 2022
	(In millions, except per share data)
RSUs, PSUs and Market-based PSUs
Awards granted	14		25		18
Estimated total grant-date fair value	$	5,316	$	4,505	$	3,492
Weighted average grant-date fair value per share	$	374.08	$	183.72	$	190.69
ESPP
Shares purchased	3		3		5
Weighted average price per share	$	158.07	$	122.54	$	56.36
Weighted average grant-date fair value per share	$	69.90	$	51.87	$	23.24

Schedule of ESPP Valuation Assumptions

The fair value of shares issued under our ESPP have been estimated with the following assumptions:

	Year Ended
	Jan 28, 2024	Jan 29, 2023	Jan 30, 2022
	(Using the Black-Scholes model)
ESPP
Weighted average expected life (in years)	0.1-2.0	0.1-2.0	0.1-2.0
Risk-free interest rate	3.9%-5.5%	—%-4.6%	—%-0.5%
Volatility	31%-67%	43%-72%	20%-58%
Dividend yield	0.1%	0.1%	0.1%

Schedule of Equity Award Transactions

The following is a summary of our equity award transactions under our equity incentive plans: 

	RSUs, PSUs and Market-based PSUs Outstanding
	Number of Shares	Weighted Average Grant-Date Fair Value
	(In millions, except per share data)
Balances, Jan 29, 2023	45	$	158.45
Granted	14	$	374.08
Vested restricted stock	(21)	$	148.56
Canceled and forfeited	(1)	$	206.35
Balances, Jan 28, 2024	37	$	245.94
Vested and expected to vest after Jan 28, 2024	37	$	245.49